CDC is bringing Ebola patient to Emory University in Atlanta

is it not a fact?

It's the appearance of the fact(s). What about all the rescue workers and victims families after 9/11? What about that Marine, Andrew Tahmooressi in a Mexican jail? What about the maimed and sick veterans? Are they not Americans?
 
it's called being an American. Because you are an American citizen, our government is willing to waste money and risk lives to show you they care.

I'd have supported an AC 130 loaded with equipment to build an intensive care unit landing over there and treating these patients, if I had known my only other option was to bring them back here to the U.S. Many people say it could have been done, and it would have been a smarter decision. But the key word people keep saying is, "ego".
 
Right, so I'm assuming if you were from West Africa then and started to show signs of the flu you wouldn't seek medical attention for fear they will infect you with some deadly disease?

If I were from west Africa I would have likely never heard of Ebola,, nor seen a Doctor in my life.. and suddenly these folks show up chattering a bunch of nonsense.

I would not be inclined (very likely) to trust a bunch of foreigners any more than the Thugs of the government.
 
I find it quite amazing, that these kinds of viruses are so easily contained. There are lots of people in the world that are whacked out, so you'd think someone that got it in their head they are chosen to destroy the world or something, would simply go to the area, get infected then intentionally spread it at one of those disgusting food markets they have over there(Vice ebola video), where the meat is just sitting out and basically rotting. 1 person could infect 100's in a day, you'd just use your blood, and casually smear it on the meat. Instant, mass ebola outbreak.



Anyway, just surprises me it never happens.
 
So according to the story that just has come out about the experimental serum and its impact on the condition of the two American aid workers it sounds like perhaps a consideration may have been made to bring them back to the U.S. to more closely monitor their recovery and what effects if any the non-FDA approved medicine had on human patients, after realizing the chance that it is going to work in reversing the effects of Ebola. If this is true it will most likely help to speed up the process in human trials on a potential treatment or vaccination for Ebola in the future.

Secret serum likely saved Ebola patients
updated 9:52 AM EDT, Mon August 4, 2014
http://www.cnn.com/2014/08/04/health/experimental-ebola-serum/index.html?hpt=hp_t1
 
Front page of Drudge now;



LEAKED CBP REPORT SHOWS ENTIRE WORLD EXPLOITING OPEN US BORDER

http://www.breitbart.com/Breitbart-...-Shows-Entire-World-Exploiting-Open-US-Border

A leaked intelligence analysis from the Customs and Border Protection (CBP) reveals the exact numbers of illegal immigrants entering and attempting to enter the U.S. from more than 75 different countries. The report was obtained by a trusted source within the CBP agency who leaked the document and spoke with Breitbart Texas on the condition of anonymity. The report is labeled as "Unclassified//For Official Use Only" and indicates that the data should be handled as "Sensitive But Unclassified (SBU)."
The numbers provided are in graphics and are broken down into “OFO” and “OBP.” The Customs and Border Protection agency is divided into the Office of Field Operations (OFO) and the Office of Border Patrol (OBP). The OFO numbers reflect anyone either turning themselves in at official U.S. points of entry, or anyone caught while being smuggled at the points of entry. The OBP numbers reflect anyone being caught or turning themselves in to Border Patrol agents between the points of entry, or anyone caught at interior checkpoints by Border Patrol agents. The “OFO Inadmissible” designation to any individual from a nation other than Mexico or Canada means that U.S. authorities took the individuals into custody. Whether they were deported or given a Notice to Appear is unknown. It is important to note these numbers do not include data from U.S. Immigration and Customs Enforcement (ICE). The unavailable ICE data are in addition to these numbers.
The report reveals the apprehension numbers ranging from 2010 through July 2014. It shows that most of the human smuggling from Syria and Albania into the U.S. comes through Central America. The report also indicates the routes individuals from North Africa and the Middle East take into the European Union, either to illegally migrate there or as a possible stop in their journey to the United States. The data are broken down further into the specific U.S. border sectors where the apprehensions and contact occurred.
Among the significant revelations are that individuals from nations currently suffering from the world’s largest Ebola outbreak have been caught attempting to sneak across the porous U.S. border into the interior of the United States. At least 71 individuals from the three nations affected by the current Ebola outbreak have either turned themselves in or been caught attempting to illegally enter the U.S. by U.S. authorities between January 2014 and July 2014.
As of July 20, 2014, 1,443 individuals from China were caught sneaking across the porous U.S. border this year alone, with another 1,803 individuals either turning themselves in to U.S. authorities at official ports of entry, or being caught attempting to illegally enter at the ports of entry. This comes amid a massive crackdown by Chinese authorities of Islamic terrorists in the Communist nation.
Twenty-eight individuals from Pakistan were caught attempting to sneak into the U.S. this year alone, with another 211 individuals either turning themselves in or being caught at official ports of entry.
Thirteen Egyptians were caught trying to sneak into the U.S. this year alone, with another 168 either turning themselves in or being caught at official ports of entry.
Four individuals from Yemen were caught attempting to sneak into the U.S. by Border Patrol agents in 2014 alone, with another 34 individuals either turning themselves in or being caught attempting to sneak through official ports of entry. Yemen is not the only nation with individuals who pose terror risks to the U.S. that the report indicates travel from. The failed nation of Somalia, known as a hotbed of Islamic terror activity, was also referenced in the report. Four individuals from Somalia were caught trying to sneak into the U.S. by Border Patrol agents in 2014. Another 290 either turned themselves in or were caught attempting to sneak in at official ports of entry. This reporter previously covered the issue of illegal immigration into the U.S. from Somalia and other nations in the Horn of Africa.
 
From the CDC


Ebola-Reston appeared in a primate research facility in Virginia, where it may have been transmitted from monkey to monkey through the air. While all Ebola virus species have displayed the ability to be spread through airborne particles (aerosols) under research conditions, this type of spread has not been documented among humans in a real-world setting, such as a hospital or household.

Science has in fact confirmed the virus can be transmitted through the air! Whether or not this applies to humans has not yet been confirmed, nor has it been ruled out! Would you be comfortable to allow an infected person cough into your face?


JWK
Actually, IIRC, two of the monkey handlers did test positive for the virus, but did not exhibit any symptoms.
 
I would like to see a better source than Natural News make that claim. I followed the imbedded link in their article to the study but can't find the information they said is there concerning airborne transmission.

It does say:


That is not exactly "Confirmed".

Hemorrhagic Fever Viruses as Biological Weapons
Medical and Public Health Management
http://jama.jamanetwork.com/article.aspx?articleid=194908

Conclusions Weapons disseminating a number of HFVs could cause an outbreak of an undifferentiated febrile illness 2 to 21 days later, associated with clinical manifestations that could include rash, hemorrhagic diathesis, and shock. The mode of transmission and clinical course would vary depending on the specific pathogen. Diagnosis may be delayed given clinicians' unfamiliarity with these diseases, heterogeneous clinical presentation within an infected cohort, and lack of widely available diagnostic tests. Initiation of ribavirin therapy in the early phases of illness may be useful in treatment of some of these viruses, although extensive experience is lacking. There are no licensed vaccines to treat the diseases caused by HFVs.


Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory
http://www.sciencedirect.com/science/article/pii/S0140673695928413

Abstract
Secondary transmission of Ebola virus infection in humans is known to be caused by direct contact with infected patients or body fluids. We report transmission of Ebola virus (Zaire strain) to two of three control rhesus monkeys (Macaca mulatta) that did not have direct contact with experimentally inoculated monkeys held in the same room. The two control monkeys died from Ebola virus infections at 10 and 11 days after the last experimentally inoculated monkey had died. The most likely route of infection of the control monkeys was aerosol, oral, or conjunctival exposure to virus-laden droplets secreted or excreted from the experimentally inoculated monkeys. These observations suggest approaches to the study of routes of transmission to and among humans.


Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread (1986)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536233/

Abstract

Between 31 July and 6 October 1979, 34 cases of Ebola virus disease (22 of which were fatal) occurred among five families in a rural district of southern Sudan; the disease was introduced into four of the families from a local hospital. Chains of secondary spread within the family units, accounting for 29 cases resulted from direct physical contact with an infected person. Among all persons with such contact in the family setting, those who provided nursing care had a 5.1-fold increased risk of infection, emphasizing the importance of intimate contact in the spread of this disease. The absence of illness among persons who were exposed to cases in confined spaces, but without physical contact, confirmed previous impressions that there is no risk of airborne transmission. While the ecology of Ebola virus is unknown, the presence of anti-Ebola antibodies in the sera of 18% of persons who were unassociated with the outbreak suggests that the region is an endemic focus of Ebola virus activity.


Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989–1990 U.S. epizootic
http://link.springer.com/chapter/10.1007/978-3-7091-7482-1_11

Summary
This study describes the pathogenesis of the Ebola-Reston (EBO-R) subtype of Ebola virus for experimentally infected cynomolgus monkeys. The disease course of EBO-R in macaques was very similar to human disease and to experimental diseases in macaques following EBO-Zaire and EBO-Sudan infections. Cynomolgus monkeys infected with EBO-R in this experiment developed anorexia, occasional nasal discharge, and splenomegaly, petechial facial hemorrhages and severe subcutaneous hemorrhages in venipuncture sites, similar to human Ebola fever. Five of the six EBO-R infected monkeys died, 8 to 14 days after inoculation. One survived and developed high titered neutralizing antibodies specific for EBO-R. The five acutely ill monkeys shed infectious virus in various bodily secretions. Further, abundant virus was visualized in alveolar interstitial cells and free in the alveoli suggesting the potential for generating infectious aerosols. Thus, taking precautions against aerosol exposures to filovirus infected primates, including humans, seems prudent. This experiment demonstrated that EBO-R was lethal for macaques and was capable of initiating and sustaining the monkey epizootic. Further investigation of this animal model should facilitate development of effective immunization, treatment, and control strategies for Ebola hemorrhagic fever.

So yeah, it's airborn...

Google does have another search engine for scientific literature...

http://scholar.google.com/

-t
 
Ebola outbreak: doctor who treated Nigeria's first victim contracts virus
Doctor was part of a team that attended to Liberian-American civil servant who collapsed on arrival at Lagos airport last month
Monday 4 August 2014 12.19 EDT

http://www.theguardian.com/world/2014/aug/04/doctor-nigeria-ebola-victim-lagos

A doctor who treated Nigeria's first Ebola victim has himself contracted the deadly virus, raising fears that the seven-month-long epidemic in three west African nations could spread in the continent's most populous nation.

The doctor was part of a team that attended to Patrick Sawyer, a 40-year-old Liberian-American civil servant who collapsed on arrival at Lagos airport last month. Sawyer had flown from Liberia's capital, Monrovia, with flight stopovers in nearby Ghana and Togo.

"As at today, one of the doctors that treated the late Mr Sawyer has tested positive to the Ebola virus," the health minister Onyebuchi Chukwu told reporters in the capital, Abuja. Officials said they had identified 70 people with whom Sawyer had been in contact, eight of whom had been transferred to isolation wards in Lagos.

The epidemic has killed 887 people in Sierra Leone, Guinea and Liberia. The three country's leaders held a regional crisis summit in Guinea's capital, Conakry, last week.

The World Health Organisation said the outbreak was moving faster than efforts to control it, and warned that the more people were infected, the greater the risk of the virus evolving into deadlier mutations.

Authorities in Lagos have rapidly rolled out a series of preventive measures, including quarantining the hospital where Sawyer was treated, distributing protective clothing to health workers and screening airport and seaport passengers arriving from at-risk countries.

Information about the virus has been widely broadcast on radio stations, and some traders have begun cashing in with the sale of hand sanitiser branded "Ebola cleansing hand gels". In the downtown business district where Sawyer was treated, a handful of traders could be seen wearing face masks.

On Sunday, health officials visited the church of the "super-pastor" TB Joshua, which attracts 50,000 worshippers weekly. "We asked that the church leadership be aware of the important role they have to play in preventing Ebola from spreading," a member of the delegation told the Guardian. "Also we warned that they do not hold 'healing sessions' as we are concerned Ebola sufferers might travel from outside the country to the church."

Attempts to contain the disease were hampered in Liberia and Sierra Leone as faith healers and crowded churches sheltered Ebola victims whom they claimed to be able to cure. Both countries eventually made such action a crime punishable with jail terms.

Passed on through contact with bodily fluids of infected patients, surfaces and bush meat, Ebola has no known cure, although chances of survival improve dramatically with early detection and treatment. It is contagious only once symptoms begin showing and can rapidly degenerate into external and internal bleeding.

The epidemic is already having an impact on Nigeria. A South Korean university banned three Nigerian students from attending a summit, and a Nigerian delegation attending a US-Africa summit is believed to have been screened on arrival in Washington.

Elsewhere, health workers and officials said they had been overwhelmed by the spiralling death toll amid a shortage of resources. The medical charity Medecins Sans Frontiers said there were critical gaps in tackling the epidemic.

"The current response to the Ebola outbreak is entirely insufficient compared to the needs, and there needs to be greater mobilisation on the ground. MSF does not have a clear overview of the most affected areas and it is believed that people are still dying in their villages without access to medical care," the organisation said on Friday.

The US said it was sending a team of 50 specialists to the region this week. The British Red Cross has launched an appeal to raise funds. The WHO has set up a $100m (£60m) fund to boost a regional emergency response.
 
MOUNT SINAI PATIENT TESTED FOR EBOLA VIRUS

Monday, August 04, 2014

UPPER EAST SIDE (WABC) -- Mount Sinai Hospital is performing tests on a patient who had recently traveled to a West African country where Ebola has been reported, the hospital says.

A male patient with high fever and gastrointestinal symptoms came to the hospital's emergency room on Monday morning.

The hospital says the patient has been placed in strict isolation and is undergoing medical screenings to determine the cause of his symptoms.

More: http://7online.com/health/mount-sinai-patient-tested-for-ebola-virus/239663/
 
An Ebola vaccine? 'There's no money in it.'
http://www.cnbc.com/id/101887615

Ebola virus: 'Horrible way to die' and no vaccine
101887814-ebola-sierra-leone.530x298.jpg

Medical staff put on protective gear at Kenema Government Hospital before taking a sample from a suspected Ebola patient in Kenema, Sierra Leone.

At least 826 people have died in West Africa from the Ebola virus.

Even though the number is expected to rise, it's still more deaths than any previous outbreak of the deadly disease.

And that ironically, may be why there's no vaccine or treatment available.

"Prior episodes burned themselves out with fewer deaths after a shorter time," said Dr. Aileen Marty, an infectious disease professor at Florida International University.

"That's meant less of a feeling that a vaccine should be on the market," she explained. "There's no money in it. But it's such a horrible way to die."

Experts say there are Ebola treatments and vaccines in various testing stages at several U.S. research centers, mostly funded by the government. Most of the drugs have been tested so far mostly on animals, with no target date for availability.

There are a few small American companies developing treatments, such as BioCryst and NancoViricides, One Canadian firm, Tekmira, is also working on a treatment, with funds from the U.S Defense Department. Larger outfits have shied away.

"It's tough to develop these drugs because they might not even be used," said Dr. Chris Milne, director of research at the Tufts Center for the Study of Drug Development.

Milne said that pharmaceutical companies can spend millions in developing flu vaccines that get thrown away because they're ineffective on new virus strains.

"It's a lot of time, effort and money to develop something like an Ebola vaccine with little guarantee of a profit," he said.
 
Back
Top